Heart to Heart: Amyloidosis: My Journey to Success - Dan Lier

Dr Sara Hassing Johansen is a Researcher within the Department of Physical Performance at The Norwegian School of Sport Sciences in Oslo, Norway. Her research interests span exercise ontology, cardiorespiratory function, CPET, lung function and physiology.Read the full trial here: https://pubmed.ncbi.nlm.nih.gov/36920460/

The IC-OS Exercise Working Group published a landmark article in the European Heart Journal. "The aim of this whitepaper is to review the current state of the literature on the effects of cardio-oncology rehabilitation and exercise (CORE). There is an urgent need to reinforce and extend the evidence informing the cardiovascular care of cancer survivors." On this episode we discuss this imporchant achievement with two of the primary authors. You can read the article here: https://pubmed.ncbi.nlm.nih.gov/40036781/Dr. Erin Howden is the head of the Cardiometabolic Health and Exercise Physiology lab, co-lead of the Physical Activity Program, at the Baker Heart and Diabetes Institute, She is an honorary senior research fellow in the Department of Cardiometabolic Medicine at the University of Melbourne, Australia and chair of the IC-OS Exercise Working Group. Dr. Fernando Rivera-Theurel is a Cardiologist with specific training in Cardiovascular Prevention & Rehabilitation and Cardio-Oncology at the University of Toronto. He leads the Cardio-Oncology Rehabilitation Program at the Peter Munk Cardiac Centre and Toronto Rehabilitation Institute. He is the Co-Chair of the Exercise and Rehabilitation IC-OS working group and the Education Co-Lead of the Canadian Cardio-Oncology Network (CCON). His research is focused on the use of technology in cardiac rehab, cardio-oncology rehabilitation and cardiac rehabilitation in cardiac amyloidosis.

In the next episode, we speak with Dan Lier, best-selling author, motivational speaker, and amyloidosis survivor and advocate. Dan discusses his journey with his treating physician, Dr. Morrie Gertz from the Mayo Clinic. Both of them provide insights into the challenges of amyloidosis diagnosis, but also the hope for treatment and life after diagnosis. You won't want to miss this inspiring episode of "Heart to Heart".Learn more about Somebody to Talk To here: https://somebodytotalkto.com/View Dan's Journey on YouTube Here:https://www.youtube.com/channel/UCbSyOgziMFG_WLx7VUb5O9g

Shaden Khalaf, MD, assistant professor, MD Anderson Cancer Center, Houston, TX, USA. She specializes in cardiac imaging and its application to cardio-oncology, today we speak with her about pericardial disease in oncology patients.

Dr David Austin is a Consultant Cardiologist at The James Cook University Hospital, Middlesbrough, South Tees NHS Foundation Trust and Honorary Senior Clinical Lecturer at Newcastle University, UK.Dr Austin is founder and co-director of the Academic Cardiovascular Unit at South Tees (https://www.southtees.nhs.uk/about/strive/research-team/academic-cardiovascular-unit/) and has established grant. In this webinar he discusses The Prospective Randomized On-X Valve Anticoagulation Clinical Trial (PROACT) with special consideration for its impact on cardio-oncology care. To veiw the entire webinar go to: https://www.radcliffecardiology.com/webinars/ic-os-journal-club-proact-trial-and-reflections-cardio-protection-trials

Dr. Khattab completed his cardio-oncology and advanced cardiac imaging fellowship at Yale University School of Medicine. He currently practices at St Francis Heart and Vascular Institute in Tulsa, OK, USA, and as an assistant professor for Oklahoma State University Cardiovascular Disease fellowship and serves as director of cardio-oncology there. In this episode he discusses radiation induced heart disease, diagnosis and management.

IC-OS President Dr. Susan Dent & treating physician Dr. Ana Barac speak with cancer survivor and patient advocate Julia Maués about her experiences. Join us for an inspiring story of survival and hope. For more information about Julia's advocacy work go to: https://graspcancer.org/

Kerry Skurka’s professional career was as a nurse in cardiology, and after her own cancer experience she moved to oncology. While caring for cancer patients she saw cardiac symptoms routinely and therefore welcomed the opportunity to be the first Cardio-Oncology Nurse Navigator at Franciscan Health in Indianapolis. Together with her cardio-oncologist Vijay Rao the program grew to 3 nurse navigators and 6 satellite clinics. During this time Kerry was given the opportunity to start the Nursing Workgroup within the International Cardio-oncology Society to grow the field of cardio-oncology nursing.Losing both her husband and father to cancer, Kerry’s passion for this work continues. Currently, she works independently in the healthcare field sharing her knowledge and experience providing consultation for nurses and programs .Yvonne Callahan Assistant Clinical Instructor, Missouri State University School of Nursing and an oncology nursing specialist.

Cezar Iliescu, MD is Professor, Department of Cardiology, and an Interventional Cardiologist, The University of Texas MD Anderson Cancer Center, Houston, TXDr. Iliescu has published extensively on the issue of managing pericardial disease in patients with cancer. Today he discusses pericardial effusions, pericardial tumors, pericarditis, and other related complications facing patients with cancer.

Dra Teresa López-Fernández is a clinical investigator and consultant cardiologist at La Paz University Hospital in Madrid, Spain. She is specializes in cardiac imaging and cardio-oncology (she is board certified by the International Cardio-Oncology Society), and currently coordinates the cardio-oncology team at La Paz University Hospital. Here we discuss risk stratification in cardio-oncology care.